AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Intrathecal baclofen: incidents with implantable drug pump system.(Safety and Efficacy Issues)

WHO Drug Information

| September 22, 2005 | COPYRIGHT 1999 World Health Organization. (Hide copyright information)Copyright

Canada -- Baclofen (Lioresal[R]) is a muscle relaxant and antispastic agent (1). Intrathecal baclofen (ITB) is indicated for the management of severe spasticity in patients with spinal cord injury or multiple sclerosis unresponsive to oral baclofen therapy or who experience unacceptable adverse reactions at effective oral doses. It is also used in patients with spasticity of cerebral origin (1). ITB injection, which delivers the drug directly to its site of action, can achieve cerebrospinal fluid levels up to 30 times higher than those achieved using oral baclofen therapy, with minimal serum concentrations (2). Patients receive baclofen as a continuous intrathecal infusion from …

Related articles from newspapers, magazines, journals, and more
Adverse reactions in children: why report?(Safety and Efficacy Issues)
Magazine article from: WHO Drug Information June 22, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily